Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - OTHER CURRENT LIABILITIES
Other Current Liabilities DNLI - Denali Therapeutics Inc.
61.2 M
LAST VALUE
13.29%
2 YEAR CAGR
25.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR